The Halo One™ Thin-Walled Guiding Sheath is indicated for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices. The Halo One™ Thin-Walled Guiding Sheath is NOT indicated for use in the neurovasculature nor the coronary vasculature.

Device Description

The Halo One™ Thin-Walled Guiding Sheath is designed to perform as both a guiding sheath and introducer sheath. The Halo One™ Thin-Walled Guiding Sheath consists of a thin-walled (1F wall thickness) sheath made from braided single-lumen tubing, fitted with a female luer hub at the proximal end and has a formed atraumatic distal tip. A supplied hemostasis valve, employing a crosscut silicone membrane and incorporating a side arm terminating in a 3-way stopcock, may be connected to the sheath luer hub. The sheath is supplied with a compatible vessel dilator that snaps securely into the hemostasis valve hub. The sheath has a strain relief feature located at the luer hub and a radiopaque platinum-iridium marker located close to the distal tip. The vessel dilator is compatible with a 0.035" (0.89 mm) guidewire. The longer sheath configurations are provided with a hydrophilic coating over the distal portion of the sheath to provide a lubricious surface to ease insertion. The short sheath configuration is marketed with an appropriately sized guide wire for initial insertion of the device.

AI/ML Overview

This document describes the 510(k) summary for the Halo One™ Thin-Walled Guiding Sheath. However, it does not detail specific acceptance criteria or study results in a format that allows for direct extraction into the requested table. Instead, it lists various in vitro tests performed to demonstrate substantial equivalence to the predicate device.

Here's an analysis based on the provided text, addressing the points you requested:

1. Table of Acceptance Criteria and Reported Device Performance:

The document lists a series of performance tests but does not explicitly state quantitative acceptance criteria or corresponding reported performance values for each. It broadly states that the device "met all predetermined acceptance criteria" and that tests "demonstrate that the technological characteristics and performance criteria... are substantially equivalent."

Acceptance Criteria (General Description)	Reported Device Performance (General Statement)
Visual Inspection (Outer Surface)	Met predetermined acceptance criteria.
Simulated Use (Packaging Removal, Haemostasis Valve Connection, Sheath Inner Surface/Dilator Compatibility, Dilator Flushability, Valve Flushability, Sheath Flushability, Guidewire Compatibility, Dilator Disengagement by Hand, Tape Adhesion)	Met predetermined acceptance criteria.
Dimensional Testing (Sheath ID, Sheath Length, Marker Band to Tip Position, Sheath OD, Dilator OD, Dilator Extension Length)	Met predetermined acceptance criteria.
Radiopacity	Met predetermined acceptance criteria.
Penetration Force of Dilator/Sheath	Met predetermined acceptance criteria.
Trackability of Dilator and Sheath	Met predetermined acceptance criteria.
Visual Inspection (Tip Rollback-Dilator & Sheath)	Met predetermined acceptance criteria.
Bend Radius/Kink	Met predetermined acceptance criteria.
Valve Leak	Met predetermined acceptance criteria.
Sheath Leak	Met predetermined acceptance criteria.
Sheath and Dilator Tensile Forces	Met predetermined acceptance criteria.
Hub Torque/Stress Cracking	Met predetermined acceptance criteria.
Hub Stress Cracking (48 Hour Test)	Met predetermined acceptance criteria.
Mini Guidewire Compatibility	Met predetermined acceptance criteria.
Packaging (Visual Inspection, Dye Penetration, Visual Inspection of Sterile Barrier Packaging Heat Seals, Seal Strength Tensile Method)	Met predetermined acceptance criteria.
Cytotoxicity (ISO 10993-1)	Met predetermined acceptance criteria.
Sensitization (ISO 10993-1)	Met predetermined acceptance criteria.
Intracutaneous Reactivity (ISO 10993-1)	Met predetermined acceptance criteria.
Acute Systemic Toxicity (ISO 10993-1)	Met predetermined acceptance criteria.
Hemocompatibility (ISO 10993-1)	Met predetermined acceptance criteria.
Material Mediated Pyrogenicity (ISO 10993-1)	Met predetermined acceptance criteria.

2. Sample Size Used for the Test Set and Data Provenance:

The document does not specify the sample size for any of the individual tests. It also does not provide details on data provenance (e.g., country of origin, retrospective/prospective). The tests listed are "in vitro tests," suggesting they were conducted in a lab setting, not with patient data.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:

Not applicable. The tests described are primarily physical, chemical, and mechanical performance tests, along with biocompatibility assessments, not clinical evaluations requiring expert ground truth for interpretation of medical images or patient outcomes.

4. Adjudication Method for the Test Set:

Not applicable, as this refers to adjudication of interpretations or diagnoses, which is not relevant for the types of in vitro tests performed for this device's 510(k) submission.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

No, an MRMC comparative effectiveness study was not done. The document describes a 510(k) submission, which focuses on demonstrating substantial equivalence through non-clinical performance data and biocompatibility, not clinical efficacy or comparative effectiveness against human readers.

6. Standalone (Algorithm Only Without Human-in-the-Loop) Performance:

Not applicable. This device is a medical instrument (a guiding sheath), not an AI algorithm.

7. Type of Ground Truth Used:

For the in vitro performance tests, the "ground truth" would be established by the specifications of the device, relevant industry standards, and regulatory guidance documents (e.g., ISO, ASTM, FDA guidance). For biocompatibility, the ground truth is adherence to the requirements of ISO 10993-1.

8. Sample Size for the Training Set:

Not applicable, as this device does not involve a "training set" in the context of machine learning or AI.

9. How the Ground Truth for the Training Set Was Established:

Not applicable for the same reason as above.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a logo for the U.S. Department of Health & Human Services. The logo features the department's symbol, which consists of a stylized human figure with three profiles facing right, representing the department's focus on people and health. The symbol is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 3, 2016

ClearStream Technologies Ltd. c/o Mark Job Responsibility Third Party Official Regulatory Technology Services LLC 1394 25th Street NW Buffalo, MN 55313

Re: K161183

Trade/Device Name: Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB Dated: May 20, 2016 Received: May 24, 2016

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{1}------------------------------------------------

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Kenneth J. Cavanaugh -S

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K161183

Device Name Halo One Thin-Walled Guiding Sheath

Indications for Use (Describe)

The Halo One Thin-Walled Guiding Sheath is indicated for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices. The Halo One Thin-Walled Guiding Sheath is NOT indicated for use in the neurovasculature nor the coronary vasculature.

Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Halo One™ Thin-Walled Guiding Sheath 510(k) Summary 21 CFR 807.92

As required by the Safe Medical Devices Act of 1990, coded under Section 513, Part (I)(3)(A) of the Food, Drug and Cosmetic Act, a 510(k) summary upon which substantial equivalence determination is based is as follows:

Submitter Information:

Applicant:	ClearStream Technologies Ltd.Moyne Upper,Enniscorthy,Co. Wexford, Ireland.
Phone:	+353 53 9237111
Fax:	+ 353 53 9237100
Contact:	Fiona Ní Mhulláin, Senior RA/QA Manager
Date	February 04, 2016

Subject Device Name:

Device Trade Name:	Halo One™ Thin-Walled Guiding Sheath
Common or Usual Name:	Catheter Introducer (21 CFR 870.1340,Product Code DYB)
Classification:	Class II
Classification Panel:	Cardiovascular

Predicate Device:

. Cordis Brite Tip Catheter Sheath Introducer System: (K984500, cleared December 23, 1998)

{4}------------------------------------------------

Device Description:

A supplied hemostasis valve, employing a crosscut silicone membrane and incorporating a side arm terminating in a 3-way stopcock, may be connected to the sheath luer hub. The sheath is supplied with a compatible vessel dilator that snaps securely into the hemostasis valve hub. The sheath has a strain relief feature located at the luer hub and a radiopaque platinum-iridium marker located close to the distal tip.

The vessel dilator is compatible with a 0.035" (0.89 mm) guidewire. The longer sheath configurations are provided with a hydrophilic coating over the distal portion of the sheath to provide a lubricious surface to ease insertion. The short sheath configuration is marketed with an appropriately sized guide wire for initial insertion of the device.

Indications for Use of Device:

Comparison of Indications for Use to Predicate Device:

The indications for use statement for the Halo One™ Thin-Walled Guiding Sheath does not raise any new issues of safety and effectiveness based on the proposed indications for use statement as compared to the predicate device. Therefore, the subject device, the Halo One™ Thin-Walled Guiding Sheath, is substantially equivalent to the predicate device.

Technological Comparison to Predicate Devices:

The Halo One™ Thin-Walled Guiding Sheath has the following similarities to the predicate device, the Cordis Brite Tip Catheter Sheath Introducer System (clearance to market via K984500 on December 23, 1998):

. Same intended use
. Same indications for use

{5}------------------------------------------------

Same target population ●
. Same operating principle
. Same fundamental scientific technology
Same sterility assurance level and method of sterilization .

The Halo One™ Thin-Walled Guiding Sheath, incorporates the following differences:

Braided shaft
Thinner wall .
Marker band .
. Hydrophilic coating
Detachable haemostatic valve
. Component materials

Performance Data:

To demonstrate substantial equivalence of the subject device, the Halo One™ Thin-Walled Guiding Sheath to the predicate device, the technological characteristics and performance criterion were evaluated. Using FDA Guidance Documents on non-clinical testing of medical devices and internal Risk Assessment procedures, the following in vitro tests were performed on the subject device:

. Visual Inspection (Outer Surface)
- o Dilator Outer Surface
- Sheath Outer Surface o
Simulated Use .
- Packaging Removal O
- Haemostasis Valve Connection o
- Sheath Inner Surface/Dilator Compatibility O
- Dilator Flushability o
- Valve Flushability O
- Sheath Flushability o
- Guidewire Compatibility o
- Dilator Disengagement by Hand o
- o Tape Adhesion
. Dimensional Testing
- o Sheath ID

{6}------------------------------------------------

Sheath Length O
Marker Band to Tip Position o
Sheath OD o
Dilator OD o
Dilator Extension Length
Radiopacity ●
Penetration Force of Dilator/Sheath .
Trackability of Dilator and Sheath .
. Visual Inspection (Tip Rollback-Dilator & Sheath)
Bend Radius/ Kink .
Valve Leak .
Sheath Leak .
Sheath and Dilator Tensile Forces ●
Hub Torque/Stress Cracking .
. Hub Stress Cracking (48 Hour Test)
Mini Guidewire Compatibility ●
Packaging .
- o Visual Inspection
- Dye Penetration o
- Visual Inspection of Sterile Barrier Packaging Heat Seals o
- o Seal Strength Tensile Method
. Cytotoxicity
Sensitization ●
Intracutaneous Reactivity .
Acute Systemic Toxicity .
. Hemocompatibility
. Material Mediated Pyrogenicity

The biocompatibility of the Halo One™ Thin-Walled Guiding Sheath was evaluated based on ISO 10993-1. The device is classified as an Externally Communicating Devices, Circulating Blood, Limited Contact (<24 hrs). The results from these tests demonstrate that the technological characteristics and performance criteria of the Halo One™ Thin-Walled Guiding Sheath are substantially equivalent to the predicate device,

{7}------------------------------------------------

and that it can perform in a manner equivalent to devices currently on the market for the same intended use.

Conclusions:

The subject device, the Halo One™ Thin-Walled Guiding Sheath, met all predetermined acceptance criteria of design verification and validation as specified by applicable standards, guidance, test protocols and/or customer inputs. The Halo One™ Thin-Walled Guiding Sheath is substantially equivalent to the legally marketed predicate device, Cordis Brite Tip Catheter Sheath Introducer System.

Regulation Number and Section

§ 870.1340 Catheter introducer.

(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).